Liver fibrosis is a serious disease characterized by excessive deposition of connective tissue, which can progress to cirrhosis if left untreated. Conventional therapeutic approaches are often insufficient to halt the remodeling of liver tissue. In pharmaceutical research, nanotechnology-based drug delivery systems are therefore gaining increasing importance – particularly those based on chitosan nanoparticles.

A novel approach to targeted drug release in the lungs

Innovative therapeutics increasingly require highly specialized delivery systems. In the recent publication “Dual-sensitive gelatin-coated chitosan microparticles (GL-ChMPs) for targeted lung delivery”, researchers present a promising strategy: chitosan-based microparticles coated with gelatin that can transport drugs directly to the lungs – smart, sensitive, and efficient.